General Information of Drug Transporter (DT)
DT ID DTD0241 Transporter Info
Gene Name SLC27A4
Transporter Name Long-chain fatty acid transport protein 4
Gene ID
10999
UniProt ID
Q6P1M0
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Chemical Compound

  DT Modulation1

PPARA protein promotes the reaction Fenofibrate results in increased expression of SLC27A4 protein [3]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Estradiol affects the expression of SLC27A4 mRNA [31]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC27A4 mRNA [22]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Valproic Acid affects the expression of SLC27A4 mRNA [38]

Regulation Mechanism

Transcription Factor Info

  1-Methyl-4-phenylpyridinium

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

1-Methyl-4-phenylpyridinium results in increased expression of SLC27A4 mRNA [11]

Regulation Mechanism

Transcription Factor Info

  2,2',3',4,4',5-hexachlorobiphenyl

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

2,2',3',4,4',5-hexachlorobiphenyl affects the expression of SLC27A4 mRNA [20]

Regulation Mechanism

Transcription Factor Info

  2,2',4,4'-tetrabromodiphenyl ether

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of SLC27A4 mRNA [21]

Regulation Mechanism

Transcription Factor Info

  3,4,5,3',4'-pentachlorobiphenyl

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

3,4,5,3',4'-pentachlorobiphenyl affects the expression of SLC27A4 mRNA [20]

Regulation Mechanism

Transcription Factor Info

  4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC27A4 mRNA [22]

Regulation Mechanism

Transcription Factor Info

  8-Bromo Cyclic Adenosine Monophosphate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SLC27A4 mRNA [23]

Regulation Mechanism

Transcription Factor Info

  abrine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

abrine results in decreased expression of SLC27A4 mRNA [24]

Regulation Mechanism

Transcription Factor Info

  ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of SLC27A4 mRNA [16]

Regulation Mechanism

Transcription Factor Info

  bisphenol A

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bisphenol A affects the expression of SLC27A4 mRNA [26]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

bisphenol A results in increased expression of SLC27A4 protein [17]

Regulation Mechanism

Transcription Factor Info

  chromium hexavalent ion

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

zinc chromate results in increased abundance of chromium hexavalent ion which results in decreased expression of SLC27A4 mRNA [27]

Regulation Mechanism

Transcription Factor Info

  cobaltous chloride

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

cobaltous chloride results in decreased expression of SLC27A4 mRNA [28]

Regulation Mechanism

Transcription Factor Info

  dicrotophos

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

dicrotophos results in increased expression of SLC27A4 mRNA [14]

Regulation Mechanism

Transcription Factor Info

  di-n-butylphosphoric acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

di-n-butylphosphoric acid affects the expression of SLC27A4 mRNA [29]

Regulation Mechanism

Transcription Factor Info

  dorsomorphin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC27A4 mRNA [22]

Regulation Mechanism

Transcription Factor Info

  epigallocatechin gallate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

potassium chromate(VI) co-treated with epigallocatechin gallate results in decreased expression of SLC27A4 mRNA [30]

Regulation Mechanism

Transcription Factor Info

  Lactic Acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Lactic Acid results in decreased expression of SLC27A4 mRNA [15]

Regulation Mechanism

Transcription Factor Info

  linalool

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

linalool results in increased expression of SLC27A4 mRNA [3]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

linalool results in increased expression of SLC27A4 protein [3]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

PPARA protein promotes the reaction linalool results in increased expression of SLC27A4 protein [3]

Regulation Mechanism

Transcription Factor Info

  Niacin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Niacin results in increased expression of SLC27A4 mRNA [11]

Regulation Mechanism

Transcription Factor Info

  N-Nitrosopyrrolidine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

N-Nitrosopyrrolidine results in increased expression of SLC27A4 mRNA [33]

Regulation Mechanism

Transcription Factor Info

  Okadaic Acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Okadaic Acid results in increased expression of SLC27A4 mRNA [34]

Regulation Mechanism

Transcription Factor Info

  Oxygen

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Oxygen deficiency results in decreased expression of SLC27A4 mRNA [35]

Regulation Mechanism

Transcription Factor Info

  Ozone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Air Pollutants results in increased abundance of Ozone which affects the expression of SLC27A4 mRNA [36]

Regulation Mechanism

Transcription Factor Info

  pentabromodiphenyl ether

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

pentabromodiphenyl ether analog results in decreased expression of SLC27A4 mRNA [21]

Regulation Mechanism

Transcription Factor Info

  perfluorooctane sulfonic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

perfluorooctane sulfonic acid results in decreased expression of SLC27A4 mRNA [16]

Regulation Mechanism

Transcription Factor Info

  potassium chromate(VI)

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

potassium chromate(VI) co-treated with epigallocatechin gallate results in decreased expression of SLC27A4 mRNA [30]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

potassium chromate(VI) results in decreased expression of SLC27A4 mRNA [30]

Regulation Mechanism

Transcription Factor Info

  sodium arsenite

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

sodium arsenite results in decreased expression of SLC27A4 mRNA [37]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

sodium arsenite results in increased expression of SLC27A4 mRNA [19]

Regulation Mechanism

Transcription Factor Info

  Tetrachlorodibenzodioxin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tetrachlorodibenzodioxin results in increased expression of SLC27A4 mRNA [10]

Regulation Mechanism

Transcription Factor Info

  zinc chromate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

zinc chromate results in increased abundance of chromium hexavalent ion which results in decreased expression of SLC27A4 mRNA [27]

Regulation Mechanism

Transcription Factor Info

Approved Drug

  Acetaminophen

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Acetaminophen inhibits the expression of SLC27A4 [2]

  DT Modulation2

Acetaminophen results in increased expression of SLC27A4 mRNA [25]

Regulation Mechanism

Transcription Factor Info

  Fenofibrate

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Fenofibrate increases the expression of SLC27A4 [3]

  Cisplatin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cisplatin inhibits the expression of SLC27A4 [4]

  Estradiol

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Estradiol increases the expression of SLC27A4 [5]

  Ivermectin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ivermectin inhibits the expression of SLC27A4 [6]

  Tretinoin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tretinoin inhibits the expression of SLC27A4 [7]

  Valproic Acid

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Valproic Acid increases the expression of SLC27A4 [8]

Drug Marketed but not Approved by US FDA

  Arbutin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Arbutin inhibits the expression of SLC27A4 [1]

Drug in Phase 2 Trial

  Bisphenol A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Bisphenol A increases the expression of SLC27A4 [17]

Drug in Phase 1 Trial

  Sodium arsenite

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sodium arsenite increases the expression of SLC27A4 [19]

  Nicotinic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Nicotinic acid increases the expression of SLC27A4 [11]

Regulation Mechanism

via enhancement of Peroxisome proliferator-activated receptor gamma (PPARG) Transcription Factor Info

Affected Drug/Substrate

Fatty acid Modulation Type Inducer

Cell System

Human colon adenocarcinoma cells (Caco-2)

Drug in Preclinical Test

  (+)-JQ1

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

(+)-JQ1 increases the expression of SLC27A4 [12]

Investigative Drug

  Milchsaure

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Milchsaure inhibits the expression of SLC27A4 [15]

Natural Product

  Linalool

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Linalool increases the expression of SLC27A4 [3]

  Tobacco Smoke Pollution

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tobacco Smoke Pollution affects the expression of SLC27A4 [18]

Traditional Medicine

  Jinfukang

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Jinfukang increases the expression of SLC27A4 [13]

Environmental toxicant

  Polychlorinated dibenzodioxin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Polychlorinated dibenzodioxin increases the expression of SLC27A4 [10]

Carcinogen

  Polychlorinated Biphenyls

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Polychlorinated Biphenyls affects the expression of SLC27A4 [9]

  Nickel

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Nickel results in increased expression of SLC27A4 mRNA [32]

Regulation Mechanism

Transcription Factor Info

Pesticide/Insecticide

  Dicrotophos

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dicrotophos increases the expression of SLC27A4 [14]

Health and Environmental Toxicant

  1-methyl-4-phenylpyridinium

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

1-methyl-4-phenylpyridinium increases the expression of SLC27A4 [11]

  Perfluorooctane sulfonic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Perfluorooctane sulfonic acid inhibits the expression of SLC27A4 [16]
References
1 Toxicogenomics of A375 human malignant melanoma cells treated with arbutin. J Biomed Sci. 2007 Jan;14(1):87-105.
2 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
3 Linalool is a PPARalpha ligand that reduces plasma TG levels and rewires the hepatic transcriptome and plasma metabolome. J Lipid Res. 2014 Jun;55(6):1098-110.
4 Low Doses of Cisplatin Induce Gene Alterations, Cell Cycle Arrest, and Apoptosis in Human Promyelocytic Leukemia Cells. Biomark Insights. 2016 Aug 24;11:113-21.
5 17 beta-Estradiol Activates HSF1 via MAPK Signaling in ER alpha-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533.
6 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975.
7 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423.
8 Stem Cell Transcriptome Responses and Corresponding Biomarkers That Indicate the Transition from Adaptive Responses to Cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
9 Exposure of human fetal penile cells to different PCB mixtures: transcriptome analysis points to diverse modes of interference on external genitalia programming. Reprod Toxicol. 2011 Jul;32(1):1-14.
10 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated production of reactive oxygen species is an essential step in the mechanism of action to accelerate human keratinocyte differentiation. Toxicol Sci. 2013 Mar;132(1):235-49.
11 Structure-dependent effects of pyridine derivatives on mechanisms of intestinal fatty acid uptake: regulation of nicotinic acid receptor and fatty acid transporter expression. J Nutr Biochem. 2014 Jul;25(7):750-7.
12 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
13 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
14 Molecular mechanisms of discrotophos-induced toxicity in HepG2 cells: The role of CSA in oxidative stress. Food Chem Toxicol. 2017 May;103:253-260.
15 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
16 An assessment of serum-dependent impacts on intracellular accumulation and genomic response of per- and polyfluoroalkyl substances in a placental trophoblast model. Environ Toxicol. 2020 Dec;35(12):1395-1405.
17 Exposure to environmental bisphenol A inhibits HTR-8/SVneo cell migration and invasion. J Biomed Res. 2020 Jun 30;34(5):369-378.
18 Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. Arch Toxicol. 2021 May;95(5):1739-1761.
19 Dynamic alteration in miRNA and mRNA expression profiles at different stages of chronic arsenic exposure-induced carcinogenesis in a human cell culture model of skin cancer. Arch Toxicol. 2021 Jul;95(7):2351-2365.
20 Transcriptomics identifies differences between ultrapure non-dioxin-like polychlorinated biphenyls (PCBs) and dioxin-like PCB126 in cultured peripheral blood mononuclear cells. Toxicology. 2011;287(1-3):113-23.
21 Cytotoxicity and gene expression profiling of two hydroxylated polybrominated diphenyl ethers in human H295R adrenocortical carcinoma cells. Toxicol Lett. 2009;185(1):23-31.
22 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
23 Mechanistic profiling of the cAMP-dependent steroidogenic pathway in the H295R endocrine disrupter screening system: new endpoints for toxicity testing. Toxicol Lett. 2012;208(2):174-84.
24 Integration of transcriptomics, proteomics and metabolomics data to reveal the biological mechanisms of abrin injury in human lung epithelial cells. Toxicol Lett. 2019;312:1-10.
25 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
26 Comprehensive analysis of transcriptomic changes induced by low and high doses of bisphenol A in HepG2 spheroids in vitro and rat liver in vivo. Environ Res. 2019 Jun;173:124-134.
27 Transcriptomic analysis reveals particulate hexavalent chromium regulates key inflammatory pathways in human lung fibroblasts as a possible mechanism of carcinogenesis. Toxicol Appl Pharmacol. 2024;485:116889.
28 Transcription and splicing regulation in human umbilical vein endothelial cells under hypoxic stress conditions by exon array. BMC Genomics. 2009;10:126.
29 Association between Organophosphate Ester Exposure and Insulin Resistance with Glycometabolic Disorders among Older Chinese Adults 60-69 Years of Age: Evidence from the China BAPE Study. Environ Health Perspect. 2023;131(4):47009.
30 Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):166-75.
31 Identification of novel low-dose bisphenol a targets in human foreskin fibroblast cells derived from hypospadias patients. PLoS One. 2012;7(5):e36711.
32 Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin. J Allergy Clin Immunol. 2015;135(3):712-20.
33 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297.
34 A multi-omics approach to elucidate okadaic acid-induced changes in human HepaRG hepatocarcinoma cells. Arch Toxicol. 2024;98(9):2919-2935.
35 Development of Long Noncoding RNA-Based Strategies to Modulate Tissue Vascularization. J Am Coll Cardiol. 2015;66(18):2005-2015.
36 Ozone exposure and blood transcriptome: A randomized, controlled, crossover trial among healthy adults. Environ Int. 2022;163:107242.
37 High-Throughput Transcriptomics of Nontumorigenic Breast Cells Exposed to Environmentally Relevant Chemicals. Environ Health Perspect. 2024;132(4):47002.
38 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.